Skip to main content
Log in

Perinatal fluoxetine treatment promotes long-term behavioral changes in adult mice

  • Original Article
  • Published:
Metabolic Brain Disease Aims and scope Submit manuscript

Abstract

Serotonin exerts a significant role in the mammalian central nervous system embryogenesis and brain ontogeny. Therefore, we investigate the effect of perinatal fluoxetine (FLX), a selective serotonin reuptake inhibitor, administration on the behavioral expression of adult male Swiss mice. For this purpose, two groups (n = 6 each, and ~ 35 g) of pregnant female Swiss mice were mated. Their offspring were treated with FLX (10 mg/Kg, s.c.) from postnatal day (PND) 5 to 15. At PND 16, one male puppy of each litter was euthanized, and the hippocampus was dissected for RNA analysis. At 70 days of life, the male offspring underwent a behavioral assessment in the open field, object recognition task, light-dark box, tail suspension and rotarod test. According to our results, the programmed animals had a decrease in TPH2, 5HT1a, SERT, BDNF, and LMX1B expression. Also, it was observed less time of immobility in tail suspension test and higher grooming time in the open field test. In the light-dark box test, the FLX-treated offspring had less time in the light side than control. We also observed a low cognitive performance in the object recognition task and poor motor skill learning in the rotarod test. These findings suggest that programming with FLX during the neonatal period alters a hippocampal serotonergic system, promoting anxiety and antidepressant behavior in adults, as well as a low mnemonic capacity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

Download references

Acknowledgements

We thank the National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Científico e Tecnológico – CNPq) and Coordination of Superior Level Staff Improvement (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior – CAPES) for the fellowship granted to graduate students present in this project, the Fundação de Amparo à Pesquisa do Estado de São Paulo to Janaina Sena de Souza (FAPESP, São Paulo, Brazil, processes #2017/07053-3 and #2018/22763-0) and Gisele Giannocco (FAPESP, São Paulo, Brazil, process #2017/23169-1). We also thank Antonio Vicente C. L. da Costa and Ipojucan Pereira de Souza, employers of Federal Rural University of Rio de Janeiro (UFRuralRJ).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Roberto Laureano-Melo.

Ethics declarations

Conflict of interest

We wish to confirm that there are no conflicts of interest associated with this publication, and there has been no significant financial support for this work that could have influenced its outcome.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Laureano-Melo, R., Dos-Santos, R.C., da Conceição, R.R. et al. Perinatal fluoxetine treatment promotes long-term behavioral changes in adult mice. Metab Brain Dis 35, 1341–1351 (2020). https://doi.org/10.1007/s11011-020-00606-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11011-020-00606-2

Keywords

Navigation